Company Overview - Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies for the oral delivery of biologics and drugs [2] - The company has developed the RaniPill® capsule, a proprietary and patented platform technology designed to replace subcutaneous injection or intravenous infusion with oral dosing [2] - Rani Therapeutics has successfully conducted several preclinical and clinical studies to evaluate the safety, tolerability, and bioavailability of the RaniPill® capsule technology [2] Upcoming Events - Rani Therapeutics will participate in the BTIG Virtual Biotechnology Conference on August 5th-6th, 2024, featuring 1x1 investor meetings [1] - The company will also present at the Canaccord 44th Annual Growth Conference on August 13th, 2024, at 3:30 PM E.T., with a format including a company presentation and 1x1 investor meetings [3]
Rani Therapeutics to Participate in August Investor Conferences